Bariatric Surgeries Market Research, 2031
The global bariatric surgeries market size was valued at $1,643.81 million in 2021 and is projected to reach $3,116.48 million by 2031, growing at a CAGR of 6.6% from 2022 to 2031. A type of weight loss surgery called bariatric surgery uses a number of different methods to aid people who are obese or extremely overweight in losing weight. These operations aim to constrict the amount of food that can be consumed, shrink the size of the stomach, and/or change how well the digestive system assimilates nutrients. Bariatric surgery is typically recommended for individuals who have a body mass index (BMI) of 40 or higher or a BMI of 35 or higher with one or more obesity-related health conditions, such as type 2 diabetes, high blood pressure, or sleep apnea.
“The COVID-19 pandemic has had a negative impact on the bariatric surgeries market size. Many hospitals and clinics have had to postpone or cancel non-urgent procedures, including bariatric surgery, to conserve resources and reduce the risk of infection. This has led to significant delays and backlogs in many parts of the world, which have impacted the ability of patients to access timely and effective treatment. As a COVID effect became decline bariatric surgery market growth is anticipated at faster rate. Many people have gained weight and are seeking effective weight loss solutions.”
Market Dynamics
Increase in obesity is major driving factor for the growth of bariatric surgeries market share. Obesity is a serious health concern that has been on the rise worldwide in recent years. Obesity is associated with numerous health problems, including cardiovascular disease, type 2 diabetes, certain cancers, and musculoskeletal disorders. Bariatric surgery is an effective treatment option for some individuals with obesity and has led to significant growth in the global bariatric surgeries market share. In addition, the rising demand for the weight loss procedures also propels the bariatric surgeries market growth. As the prevalence of overweight and obesity continues to rise globally, there has been a significant surge in the demand for weight loss procedures in recent years. The choice of weight reduction technique relies on the individual's specific demands, health situation, and preferences. Weight loss surgeries can include both surgical and non-surgical options. Weight reduction procedures have become a more acceptable and approachable choice for those who want to enhance their health and self-confidence, despite the stigma that still surrounds weight loss and body image.
Furthermore, advancements in technology and surgical techniques have made weight loss procedures more effective, safe, and accessible. Many key market players are launching device which anticipate the market growth. For an instance, In, May 2021, Standard Bariatrics which is now part of Teleflex Corporation announced that its novel Titan SGS stapling technology, designed specifically for bariatric sleeve surgery, has been cleared by the US Food and Drug Administration (FDA) The Titan SGS first-of-its-kind design offers surgeons performing sleeve gastrectomy procedures the industry’s longest continuous staple cutline of 23 centimeters. Thus, launch of such innovative products for the bariatric surgery drives the further growth of the market. Thus, advancements in surgical techniques and technology have also contributed to the growth of the bariatric surgery market.
Moreover, in recent years, there has been a significant increase in focus on health and well-being, both in individual and societal levels, also propels the market growth. Bariatric surgery is increasingly viewed as an effective way to improve overall health and quality of life for individuals with obesity and related health problems. As individuals become more aware of the health risks associated with obesity, many are turning to bariatric surgery as a way to improve their health and reduce their risk of chronic diseases. As there in surge in focus on health and well-being, growth of the bariatric surgery market is anticipated. It evolves and expand to meet the needs of individuals seeking to improve their health and quality of life through weight loss surgery.
However, high cost require for the bariatric surgery restrains the growth of the market. Bariatric surgery is a major surgery that requires a highly trained surgical team and specialized equipment. In addition, the procedure often involves a range of preoperative and postoperative care, including medical evaluations, dietary counseling, and follow-up appointments, which can further increase the cost. On the other hand, increase in demand for minimally invasive procedure is a lucrative opportunity for the bariatric surgery market growth during the forecast period. Minimally invasive procedures, such as laparoscopic sleeve gastrectomy, have gained popularity due to their lower risk of complications, shorter recovery times, and reduced hospital stays compared to traditional open surgery.
In addition, minimally invasive bariatric surgery patients would be able to resume regular activities earlier, which can enhance their quality of life and lower overall treatment costs. E-commerce (electronic commerce) has become a vital tool for small and large businesses globally, due to rise in preference of consumers for online shopping over traditional purchasing methods. Various animations through health apps to educate people regarding obesity and risks associated with it have contributed toward the growth of bariatric surgery market.
The outbreak of COVID-19 has disrupted workflows in the health care sector around the world. The disease has forced a number of industries to shut their doors temporarily, including several sub-domains of health care. The COVID-19 pandemic has had a considerable impact on the market for bariatric surgery. The pandemic has disrupted supply chains, which has resulted in a shortage of medical supplies, particularly bariatric surgeries. This has made it difficult for medical staff to obtain the equipment they need to carry out surgery, resulting in cancellations or delays.
Segmental Overview
The bariatric surgery market is segmented into device, procedure, end user, and region. On the basis of device, the market is categorized into assisting devices, implantable devices and others. On the basis of procedure, the market is segregated into sleeve gastrectomy, gastric bypass and others. On the basis of end user, the market is classified into hospitals and others. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
By Device
Assisting Devices segment held a dominant position in 2021 and would continue to maintain the lead over the forecast period.
By Device Type:
The market is categorized into assisting devices, implantable devices and others. The assisting devices segment accounted for largest share in terms of revenue in 2021 and is expected to register highest CAGR owing to rise in adoption of these devices and rise in R&D activities for development of assisting devices by key players of the market.
By Procedure
Sleeve Gastrectomy segment is projected as one of the most lucrative segment.
By Procedure:
The market is classified into sleeve gastrectomy, gastric bypass and others. The sleeve gastrectomy segment dominated the market in terms of revenue in 2021. This is attributed to rise in adoption of these procedures owing to effectiveness and various improvements in these procedures. Moreover, the gastric bypass segment is projected to register a highest CAGR during the forecast period, owing to rising prevalence of obesity and high success rate of these devices as compared to other devices.
By End User
Hospitals segment is projected as one of the most lucrative segment.
By End Users:
The market is bifurcated into hospitals and others. The hospitals segment accounted for largest share in 2021 and is expected to register highest CAGR during the forecast period owing to well-resourced diagnostic rooms, availability of highly qualified healthcare practitioners, and increase in health coverage for hospital-based healthcare services from several private & group insurance programs.
By Region
North America held a dominant position in 2021 and would continue to maintain the lead over the forecast period.
By Region:
The bariatric surgeries industry is analyzed across North America, Europe, Asia-Pacific, and LAMEA. North America had the highest market share in 2021 and is expected to maintain its lead during the bariatric surgeries market forecast period, owing to increase in prevalence of obesity and rise in healthcare infrastructure. In addition, rise in no of key players manufacturing bariatric surgery devices and increase in awareness regarding health and well-being further drives the market growth in this region. However, Asia-Pacific is expected to witness highest growth during the forecast period, owing to factors such as rise in investments for manufacturing of high-quality devices used in bariatric surgery, increasing obesity. In addition, increase in healthcare infrastructure in this region further propel the market growth.
Presence of several major players, such as Medtonic Plc., Teleflex incorporated Johnson & Johnson and technological advancements in the region drive the growth of the market. In addition, surge in prevalence of obesity in the region is boosting the growth of the market. Furthermore, presence of well-established healthcare infrastructure and high purchasing power are expected to drive the market growth. Furthermore, acquisitions, product launch, and product approval adopted by the key players in this region boost the growth of the market.
Asia-Pacific expected to grow at the highest rate during the forecast period. The bariatric surgeries industry growth in this region is attributable to presence of pharmaceutical companies in the region as well as growth in the purchasing power of populated countries, such as China and India. Moreover, Asia-Pacific offers profitable opportunities for key players operating in the bariatric surgery market, thereby registering the fastest growth rate during the forecast period, owing to the growing infrastructure of industries, rising disposable incomes, as well as well-established presence of domestic companies in the region. In addition, rise in obese population within the region provides great opportunity for new entrants in this region.
Competitive Analysis
Competitive analysis and profiles of the major players in the disruptive behavior disorder treatment, such as Asenus Surgical US, Inc., B Braun Melsungen AG, Cousin Surgery, Johnson & Johnson, Olympus Corporation, Richard Wolf GmbH, SPATZ FIGA, Inc., Teleflex Incorporated, and USGI Medical, Inc. Major players have adopted acquisition, agreement, product approval and product launch as key developmental strategies to improve the product portfolio of the bariatric surgery market.
Agreement in The Bariatric Surgeries Market
- In February 2023, Teleflex Incorporated, announced it was awarded a group purchasing organization (GPO) agreement with Premier®, Inc. for the Titan SGS® powered stapling device, expanding access to this innovative technology for surgeons affiliated with Premier.
- Acquisition in The Bariatric Surgeries Market
- In September 2022, Teleflex Incorporated, announced that it has completed the previously announced acquisition of Standard Bariatrics, Inc., which has commercialized an innovative powered stapling technology for bariatric surgery.
Recent Product Launch in The Bariatric Surgeries Market
- In September 2022, Olympus Corporation announced the launch of VISERA ELITE III, its newest surgical visualization platform that addresses the needs of healthcare professionals (HCPs) for endoscopic procedures across multiple medical disciplines.
- In, May 2021, Standard Bariatrics which is now part of Teleflex Corporation announced that its novel Titan SGS stapling technology, designed specifically for bariatric sleeve surgery, has been cleared by the US Food and Drug Administration (FDA).1 The Titan SGS first-of-its-kind design offers surgeons performing sleeve gastrectomy procedures the industry’s longest continuous staple cutline of 23 centimeters.
- In December 2021, Spatz FGIA, Inc., announced that the U.S. Food and Drug Administration (FDA) has approved the Spatz3 Gastric Balloon, the first adjustable gastric balloon system, to aid in weight loss for adult patients struggling with obesity.
Key Benefits For Stakeholders
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the bariatric surgeries market analysis from 2021 to 2031 to identify the prevailing bariatric surgeries market opportunity.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the bariatric surgeries market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global bariatric surgeries market trends, key players, market segments, application areas, and market growth strategies.
Bariatric Surgeries Market Report Highlights
| Aspects | Details |
 Market Size By 2031 | USD 3.1 billion |
 Growth Rate | CAGR of 6.6% |
 Forecast period | 2021 - 2031 |
 Report Pages | 299 |
 By Device |
|
 By Procedure |
|
 By End User |
|
 By Region |
|
 Key Market Players | Cousin Biotech, Covidien Plc., Intuitive Surgical Inc., GI Dynamics Inc., SPATZ FIGA, Inc., SemiLEDs Ltd., TransEnterix Inc., Mediflex Surgical Procedures, USGI Medical Inc., Johnson & Johnson |
Analyst Review
This section provides various opinions of top-level CXOs in the global bariatric surgery market. According to the insights of CXOs, increase in demand for bariatric surgery and rise in obesity globally are expected to offer profitable opportunities for the expansion of the market.
CXOs further added that increase in demand for weight loss surgeries in developing regions largely contributed to the market revenue in 2021 and is expected to maintain this trend throughout the forecast period. In addition, awareness regarding bariatric surgery for weight loss procedure across the globe and increase in demand for next generation devices in many countries significantly contribute toward revenue generation.
Furthermore, North America is the largest revenue contributing region, owing to rise in awareness about bariatric surgery and surge in number of obese people in the region. Upsurge in healthcare expenditure in the emerging economies is anticipated to offer lucrative opportunities for market expansion. Moreover, factors such as increase in awareness regarding bariatric surgery, rise in disposable income, and surge in focus on health drive the growth of market during the forecast period.
Loading Table Of Content...
